rss
Evid Based Nurs 2009;12:105 doi:10.1136/ebn.12.4.105
  • Treatment

Review: inhaled corticosteroids reduce wheezing and asthma exacerbations in infants and preschool children

Question

Do inhaled corticosteroids (ICSs) reduce wheezing/asthma exacerbations (WAEs) in infants and preschool children with a previous diagnosis of wheezing or asthma?

Review scope

Included studies were randomised controlled trials (RCTs) of ≥4 weeks of treatment that compared an ICS with placebo in infants and children ≤5 years of age with a diagnosis of wheezing or asthma for ≥6 months before study entry. Outcomes were WAEs (worsening symptoms that required systemic corticosteroids), withdrawal from study due to WAEs, change in symptom score, change in salbutamol(albuterol) use, and change in pulmonary function (FEV1 and peak expiratory flow [PEF]).

Review methods

Medline, EMBASE/Excerpta Medica, and Cochrane Central Register of Controlled Trials (all to Mar or second quarter 2008) were searched for RCTs. 29 RCTs {n = 3992, mean age 40 mo}* …

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.